Emelyne Dejeux

Summary

Country: France

Publications

  1. pmc DNA methylation profiling in doxorubicin treated primary locally advanced breast tumours identifies novel genes associated with survival and treatment response
    Emelyne Dejeux
    Laboratory for Epigenetics, Centre National de Genotypage, CEA Institut de Génomique, Evry, France
    Mol Cancer 9:68. 2010
  2. pmc Quantitative DNA methylation analyses reveal stage dependent DNA methylation and association to clinico-pathological factors in breast tumors
    Jovana Klajic
    Department of Clinical Molecular Biology and Laboratory Science EpiGen, Akershus University Hospital, Division of Medicine, 1476 Lørenskog, Norway
    BMC Cancer 13:456. 2013
  3. pmc Data integration from two microarray platforms identifies bi-allelic genetic inactivation of RIC8A in a breast cancer cell line
    Aslaug Aamodt Muggerud
    Department of Genetics, Institute for Cancer Research, Norwegian Radium Hospital, Oslo University Hospital, 0310 Oslo, Norway
    BMC Med Genomics 2:26. 2009
  4. ncbi request reprint Identification and quantification of differentially methylated loci by the pyrosequencing technology
    Emelyne Dejeux
    Laboratory for Epigenetics, Centre National de Genotypage, CEA Institut de Génomique, Evry, France
    Methods Mol Biol 507:189-205. 2009
  5. ncbi request reprint Hypermethylation of the IGF2 differentially methylated region 2 is a specific event in insulinomas leading to loss-of-imprinting and overexpression
    Emelyne Dejeux
    Laboratory for Epigenetics CEA Institut de Génomique, Centre National de Génotypage, 91000 Evry, France
    Endocr Relat Cancer 16:939-52. 2009

Collaborators

Detail Information

Publications5

  1. pmc DNA methylation profiling in doxorubicin treated primary locally advanced breast tumours identifies novel genes associated with survival and treatment response
    Emelyne Dejeux
    Laboratory for Epigenetics, Centre National de Genotypage, CEA Institut de Génomique, Evry, France
    Mol Cancer 9:68. 2010
    ..In this study, we aimed to identify DNA methylation based biomarkers to distinguish patients with locally advanced breast cancer who may benefit from neoadjuvant doxorubicin treatment...
  2. pmc Quantitative DNA methylation analyses reveal stage dependent DNA methylation and association to clinico-pathological factors in breast tumors
    Jovana Klajic
    Department of Clinical Molecular Biology and Laboratory Science EpiGen, Akershus University Hospital, Division of Medicine, 1476 Lørenskog, Norway
    BMC Cancer 13:456. 2013
    ..In the present study we investigate stage specific changes in the DNA methylation patterns in order to identify valuable markers to understand how these changes affect breast cancer progression...
  3. pmc Data integration from two microarray platforms identifies bi-allelic genetic inactivation of RIC8A in a breast cancer cell line
    Aslaug Aamodt Muggerud
    Department of Genetics, Institute for Cancer Research, Norwegian Radium Hospital, Oslo University Hospital, 0310 Oslo, Norway
    BMC Med Genomics 2:26. 2009
    ....
  4. ncbi request reprint Identification and quantification of differentially methylated loci by the pyrosequencing technology
    Emelyne Dejeux
    Laboratory for Epigenetics, Centre National de Genotypage, CEA Institut de Génomique, Evry, France
    Methods Mol Biol 507:189-205. 2009
    ....
  5. ncbi request reprint Hypermethylation of the IGF2 differentially methylated region 2 is a specific event in insulinomas leading to loss-of-imprinting and overexpression
    Emelyne Dejeux
    Laboratory for Epigenetics CEA Institut de Génomique, Centre National de Génotypage, 91000 Evry, France
    Endocr Relat Cancer 16:939-52. 2009
    ....